
28 July 2026: Pfizer has appointed Manas Pandit as its new Senior Director, AI and Enterprise Product Management, based in New York. This executive addition highlights the biopharmaceutical giant’s commitment to leveraging advanced artificial intelligence to drive comprehensive business transformation and elevate patient outcomes on a global scale.
To this strategic mandate, Manas brings more than 25 years of distinguished leadership experience spanning healthcare, life sciences, financial services, and technology consulting. Prior to joining the enterprise, he spent over four years at Vertex Pharmaceuticals, most recently serving as Senior Director of Business Engagement and Technology for Commercial IT, as well as Senior Director of US Patient Services.
His career trajectory includes roles as Principal Director of Life Sciences at LTI (Larsen & Toubro Infotech) and a seven-year tenure as Client Partner & Director of Life Sciences at Cognizant, where he worked on AI-powered intelligent search, Software-as-Medical-Device (SaMD) initiatives, and advanced analytics. His foundational expertise was built through prominent leadership positions at Infosys, IBM Global Business Services, Calypso Technology, and a nearly nine-year tenure at Tata Consultancy Services (TCS).
Taking command of the firm’s AI-driven enterprise product strategy, Manas steps into a mandate focused on driving tangible, real-world impact. Reflecting on his transition, he emphasized a core philosophy: within the life sciences sector, artificial intelligence holds true value only when it actively helps bring therapies to patients with greater speed, enhanced safety, and increased affordability.Embracing this exciting new chapter, Manas highlighted that the rapid pace of technological adoption at the company, perfectly matched by an unwavering focus on patient outcomes, is precisely the kind of transformative work he is most passionate about championing
Curated by SSF Global
Tracking the shifts shaping GCCs, enterprise ecosystems, and the future of global business.

Ask an Expert
